Europe

Velocity Aggressively Expands MASH/MASLD Capabilities with Latest Site Acquisitions

Velocity Expands MASH/MASLD Capabilities With New Sites in Seattle, WA, and Waco, TX

Velocity Clinical Research, the leading multi-specialty clinical sites business, announced it has acquired Impact Research Institute (Waco, TX) and the clinical trials unit of Liver Institute Northwest (Seattle, WA), aggressively expanding its capabilities in liver disease research, including MASH (metabolic dysfunction-associated steatohepatitis) and MASLD (metabolic dysfunction-associated steatotic liver disease). According to the NASH education program, … Read more

Velocity Eczema Trials Enhance Patient Quality of Life

Shiva Muthiah, Director of UK Operations for Velocity, smiles as she recalls the triumph of a teenage patient battling a painful eczema skin condition. “He used to wear long sleeves and other clothing designed to hide the marks on his skin, but almost immediately after beginning treatment in our clinical trial, the improvement was dramatic … Read more

Velocity Opens Three UK Greenfield Clinical Research Sites

Velocity Clinical Research, the leading multi-specialty clinical sites business, announced it is opening greenfield clinical research sites in Bristol, Leicester, and Romford, demonstrating the company’s commitment to the U.K. market.  The sites launch at a time when clinical trial activity in the U.K. has fallen in recent years. The number of patients enrolled in commercial … Read more